NORWALK, Conn., Jan. 27, 2015 /PRNewswire/ -- HealthPrize Technologies, an industry-leading medication adherence and digital patient-engagement company, today announced the formation of a new five-member Board of Advisors. These new advisors will aid the company in thought leadership, product evolution and refinement, and business strategy. "Each advisor brings a wealth of experience and a unique perspective to HealthPrize during this critical growth phase," says Thomas Kottler, CEO and Cofounder of HealthPrize. "We look forward to the synergy of these diverse minds working together."
Katherine Milkman, PhD, is the James G. Campbell, Jr. Assistant Professor at the Wharton School at the University of Pennsylvania. Her research relies heavily on "big data" to document various ways in which individuals systematically deviate from making optimal choices. She is also an Associate Editor for the Behavioral Economics Department at the journal Management Science. According to Milkman, "There are big opportunities to improve medication adherence through the application of insights from the growing field of behavioral economics."
Walid Gellad, MD, MPH, is Assistant Professor of Medicine in the School of Medicine at the University of Pittsburgh and Assistant Professor of Health Policy and Management in the Graduate School of Public Health. He codirects the University's Center for Pharmaceutical Policy and Prescribing. In addition to his research and policy activities, he is a practicing, board-certified general internist. Dr. Gellad is a nationally recognized authority on medication adherence, having authored several reviews on the barriers to medication adherence for patients.
Gabe Zichermann is Chair of GSummit, where top gamification experts across industries gather to share knowledge and insights about customer and employee engagement and loyalty. He is also Founder and Editor of Gamification.Co and EQ magazine. Gabe is an author, highly rated public speaker, and entrepreneur whose most recent book, The Gamification Revolution, looks at how leaders are leveraging gamification strategy to beat the competition.
James Kalustian is the recent Past Chairman of the Ambassadors Group, a socially conscious student education travel company. From 2012 to 2014, he was the Chief Operating Officer of RxAnte (acquired by Millenium Labs), a venture-backed, science-based information technology solutions company focused on improving quality and lowering the cost of healthcare by improving medication adherence for chronic disease. He was also a Senior VP and Cofounder of HealthCare Resources Information Network (HRInet), VP/General Manager Emerging Industries Business Unit, and VP, Innovation Management and Performance Assurance at Fair Isaac Corporation (FICO). Kalustian says, "I am very much looking forward to applying my operating experience in healthcare technology and analytics, and in entrepreneurial growth companies, to help enhance HealthPrize's unique gamification and education approach to medication adherence."
Michael Lewis, CFA, is currently a management consultant providing strategic and financial advice to healthcare companies and healthcare investment firms. He is the former Head of Strategy and Business Development at Prodigy Health, a $600M Aetna subsidiary, and was a member of Aetna's Corporate Development and Strategy group, where he completed a number of acquisitions, strategic alliances, joint ventures, and the formation of Accountable Care Organizations (ACOs). He also has experience as an investor in high-growth entrepreneurial companies.
See the HealthPrize website (https://healthprize.com/board/board-of-advisors/) for a more detailed bio of each advisor.
HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform provides an innovative approach to addressing the problem of medication nonadherence with an online and mobile-based program that is fun, educational, and rewarding. The HealthPrize system leverages gaming dynamics, behavioral economics, and proven concepts from consumer marketing to maximize engagement while using education to strengthen the intrinsic motivation required for long-term persistence to prescribed medications. For more information, visit www.healthprize.com and follow us on Twitter at @HealthPrize.
Director of Communications, HealthPrize Technologies
SOURCE HealthPrize Technologies